Preview

Head and Neck Tumors (HNT)

Advanced search

A biopsy of the signaling lymph node in case of early oral cancer (cT1–2N0M0) by the lymphoscintigraphic method: one center study

https://doi.org/10.17650/2222-1468-2019-9-1-68-73

Abstract

The study objective is to evaluate the possibility of determining the signaling lymph node (SLN)  in oral cancer (T1–2N0M0) with lymphoscintigraphic method.

Materials and methods. In 2016–2018,  SLNs were determined for 23 patients with oral cancer (cT1–2N0M0): for 15 patients with cancer of the tongue, for 8 patients with cancer of the floor of the mouth cavity. SLNs were determined by radiolymphoscintigraphic method by peritumoral administration of Tehnefit radiopharmaceutical in a dose of 40 to 80 MBq, depending on the timing of the signal lymph node biopsy. Visualization of the signaling lymph node was carried out by planar scintigraphy and single-photon emission computed tomography combined with x-ray computed tomography. Intraoperative SLN was detected using intraoperative radiometry using a gamma probe.

Results. In cancer of the floor of the mouth, SLNs were identified only in 2 (25 %) of 8 cases. In cancer of the language, SLN were identified in 14 (93.3 %) of 15 cases. In total, SLNs were diagnosed with cancer in 17 patients. In 4 (26.7 %) of 15 patients, cancer metastases in SLNs were identified. False negative results were obtained in 6.7 % of cases.

Conclusion. A biopsy of the SLN by the lymphoscintigraphic method has a high diagnostic value for staging the early stages of cancer of the tongue.

About the Authors

Sh. I. Musin
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


S. V. Osokin
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


Т. G. Yatsenko
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


A. V. Sultanbaev
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


М. М. Zamilov
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


М. М. Vakhito
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


V. V. Ilyin
Republican Clinical Oncology Dispensary
Russian Federation
73/1 Oktyabrya Ave., Ufa 450054.


References

1. The Global Cancer Observatory. Available at: http://gco.iarc.fr.

2. Layland M.K., Sessions D.G., Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115(4):629—39. DOI: 10.1097/01.mlg.0000161338.54515.b1. PMID: 15805872.

3. Stoeckli S.J., Haerle S.K., Strobel K. et al. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck 2012;34(4):469—76. DOI: 10.1002/hed.21764. PMID: 21604319.

4. Hakeem A.H., Pradhan S.A., Tubachi J., Kannan R. Outcome of per oral wide excision of T1-2 N0 localized squamous cell cancer of the buccal mucosa — analysis of 156 cases. Laryngoscope 2013;123(1): 177-80. DOI: 10.1002/lary.23707. PMID: 22952001.

5. Koerdt S., Rockl J., Rommel N. et al. Lymph node management in the treatment of oral cancer: analysis of a standardized approach. J Craniomaxillofac Surg 2016;44(10):1737—42. DOI: 10.1016/j.jcms.2016.08.002. PMID: 27580851.

6. Weiss M.H., Harrison L.B., Isaacs R.S. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994;120(7):699—702. DOI: 10.1001/archotol.1994.01880310005001. PMID: 8018319.

7. Okura M., Aikawa T., Sawai N.Y. et al. Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 2009;45(10):908—11. DOI: 10.1016/j.oraloncology.2009.03.013. PMID: 19457712.

8. Duvvuri U., Simental A.A. Jr, D'Angelo G. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 2004;114(12):2228—34. DOI: 10.1097/01.mlg.0000149464.73080.20. PMID: 15564851.

9. D'Cruz A.K., Vaish R., Kapre N., Dandekar M. et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 2015;373(6):521—29. DOI: 10.1056/NEJMoa1506007. PMID: 26027881.

10. Umeda M., Shigeta T., Takahashi H. et al. Shoulder mobility after spinal accessory nerve-sparing modified radical neck dissection in oralcancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(6):820—4. DOI: 10.1016/j.tripleo.2009.11.027. PMID: 20299249.

11. Alkureishi L.W., Burak Z., Alvarez J.A. et al. Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol 2009;16(11):3190—210. DOI: 10.1245/s10434-009-0726-8. PMID: 19795174.

12. Schilling C., Stoeckli S.J., Haerle S.K. et al. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer 2015;51(18):2777—84. DOI: 10.1016/j.ejca.2015.08.023. PMID: 26597442.

13. Cramer J.D., Sridharan S., Ferris R.L. Sentinel lymph node biopsy versus elective neck dissection for stage I to II oral cavity cancer. Laryngoscope 2019;129(1):162—9. DOI: 10.1002/lary.27323. PMID: 30284248.

14. Civantos F.J., Zitsch R.P., Schuller D.E. et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1— T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol 2010;28(8):1395—400. DOI: 10.1200/JCO.2008.20.8777. PMID: 20142602.

15. National Comprehensive Cancer Network. Available at: https://www.nccn.org.

16. Govers T.M., Hannink G., Merkx M.A. et al. Sentinel node biopsy for squamous cell carcinoma of the oral cavity and oropharynx: a diagnostic meta-analysis. Oral Oncol 2013;49(8):726—32. DOI: 10.1016/j.oraloncology.2013.04.006. PMID: 23680537.

17. Haerle S.K., Hany T.F., Strobel K. et al. Is there an additional value of SPECT/CT over planar lymphoscintigraphy for sentinel node mapping in oral/oropharyngeal squamous cell carcinoma? Ann Surg Oncol 2009;16(11):3118—24. DOI: 10.1245/s10434-009-0632-0. PMID: 19636629.

18. Bilde A., Von Buchwald C., Mortensen J. et al. The role of SPECT-CT in the lymphoscintigraphic identification of sentinel nodes in patients with oral cancer. Acta Otolaryngol 2006;126(10):1096—103. DOI: 10.1080/00016480600794453. PMID: 16923717.

19. Den Toom I.J., van Schie A., van Weert S. et al. The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer. Eur J Nucl Med Mol Imaging 2017;44(6):998—1004. DOI: 10.1007/s00259-017-3613-8. PMID: 28132110.

20. Ross G.L., Soutar D.S., MacDonald D.G. et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004;11(7):690—6. DOI: 10.1245/ASO.2004.09.001. PMID: 15197011.

21. Uren R.F., Thompson J.F., Howman-Giles R.B. Lymphatic drainage of the skin and breast. Singapore: Harwood Academic Publishers, 1999. Pp. 40—49.

22. Vorburger M.S., Broglie M.A., Soltermann A. Validity of frozen section in sentinel lymph node biopsy for the staging in oral and oropharyngeal squamous cell carcinoma. J Surg Oncol 2012;106(7):816—9. DOI: 10.1002/jso.23156. PMID: 22585742.


Review

For citations:


Musin Sh.I., Osokin S.V., Yatsenko Т.G., Sultanbaev A.V., Zamilov М.М., Vakhito М.М., Ilyin V.V. A biopsy of the signaling lymph node in case of early oral cancer (cT1–2N0M0) by the lymphoscintigraphic method: one center study. Head and Neck Tumors (HNT). 2019;9(1):68-73. (In Russ.) https://doi.org/10.17650/2222-1468-2019-9-1-68-73

Views: 954


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2222-1468 (Print)
ISSN 2411-4634 (Online)